UMAN. Nov 30 (Interfax-Ukraine) – Private joint-stock company Technolog (Uman, Kyiv region), part of Lekhim group of pharmaceutical companies, seeks to have prequalification of the World Health Organization (WHO) in 2017. This would help to double or triple exports of medicines to treat TB.
“We are preparing papers for receiving WHO prequalification. By late 2017 we seek to receive it. With WHO prequalification we would be able to double or triple exports of medicines to treat TB,” Technolog Director General Serhiy Remsky told reporters on Monday.
He said that in general exports totals up to 15% of total sales of the company. The company mainly supplies medicines to the CIS countries.
“Our medicines are registered in the CIS countries. We have plans to enter foreign markets,” Remsky said.
He said that Technolog is to spend money on papers and tests to receive WHO prequalification.
Remsky said that spending on confirmation of bioequivalence of one medicine could total up to UAH 1.5 million and at least 12 volunteers are tested. Technolog involved 32 volunteers.
He said that after prequalification for anti-TB medicines, the company would consider having prequalification for HIV/AIDS medicines.
